(UTI) Universal Technical - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US9139151040

Technical,Trades, Automotive,Welding,Diesel

UTI EPS (Earnings per Share)

EPS (Earnings per Share) of UTI over the last years for every Quarter: "2020-03": 0.35407066052227, "2020-06": -0.40690649247094, "2020-09": 0.19561459375853, "2020-12": 0.033161859268786, "2021-03": -0.047219339478664, "2021-06": 0.090810025426807, "2021-09": 0.36095295175307, "2021-12": 0.44149886810437, "2022-03": 0.21994257686326, "2022-06": 0.025348047027693, "2022-09": 0.082528661862948, "2022-12": 0.076958846779819, "2023-03": 0.10071484386305, "2023-06": -0.014941145389967, "2023-09": 0.19248219618654, "2023-12": 0.27749138598787, "2024-03": 0.14217637392733, "2024-06": 0.090717184400648, "2024-09": 0.34004764998917, "2024-12": 0.39983034328412, "2025-03": 0.20644998376682, "2025-06": 0.19165992630538,

UTI Revenue

Revenue of UTI over the last years for every Quarter: 2020-03: 82.717, 2020-06: 54.483, 2020-09: 76.327, 2020-12: 76.125, 2021-03: 77.709, 2021-06: 83.768, 2021-09: 97.481, 2021-12: 105.075, 2022-03: 102.086, 2022-06: 100.966, 2022-09: 110.638, 2022-12: 120.004, 2023-03: 163.82, 2023-06: 153.286, 2023-09: 170.298, 2023-12: 174.695, 2024-03: 184.176, 2024-06: 177.458, 2024-09: 196.358, 2024-12: 201.429, 2025-03: 207.447, 2025-06: 204.298,

Description: UTI Universal Technical

Universal Technical Institute Inc (NYSE:UTI) is a common stock listed on the New York Stock Exchange, operating in the Education Services sub-industry. The companys market capitalization stands at $1.818 billion, indicating a mid-cap status.

The stocks valuation metrics suggest a relatively high price-to-earnings ratio of 31.92, which may indicate overvaluation or high growth expectations. The forward P/E ratio is slightly lower at 27.70, potentially signaling a decrease in earnings growth rate. Return on Equity (RoE) is 22.12%, indicating a decent return for shareholders. To further assess the companys performance, key drivers such as revenue growth, student enrollment numbers, and program offerings should be examined.

Key Performance Indicators (KPIs) for UTI may include student retention rates, graduate employment rates, and revenue per student. Economic drivers influencing the companys performance could be the demand for skilled technicians in the automotive and industrial industries, government policies on vocational training, and competition in the for-profit education sector. Analyzing these factors can provide insights into the companys future prospects and potential stock performance.

To evaluate the stocks potential, its essential to consider its beta of 1.585, indicating higher volatility compared to the overall market. This, combined with the stocks current price and moving averages, may suggest a potential trading range or trend reversal. A thorough analysis of the companys financials, management team, and industry trends is necessary to make an informed investment decision.

UTI Stock Overview

Market Cap in USD 1,402m
Sub-Industry Education Services
IPO / Inception 2003-12-17

UTI Stock Ratings

Growth Rating 83.1
Fundamental 79.8%
Dividend Rating 4.42
Rel. Strength 27.2
Analysts 4.83 of 5
Fair Price Momentum 27.24 USD
Fair Price DCF 4.42 USD

UTI Dividends

Currently no dividends paid

UTI Growth Ratios

Growth Correlation 3m -86.9%
Growth Correlation 12m 86.3%
Growth Correlation 5y 86%
CAGR 5y 26.31%
CAGR/Max DD 5y 0.51
Sharpe Ratio 12m 0.37
Alpha 31.19
Beta 1.058
Volatility 67.29%
Current Volume 1387.3k
Average Volume 20d 624.9k
Stop Loss 24.3 (-6.6%)
Signal -0.55

Piotroski VR‑10 (Strict, 0-10) 7.5

Net Income (63.1m TTM) > 0 and > 6% of Revenue (6% = 48.6m TTM)
FCFTA 0.10 (>2.0%) and ΔFCFTA 3.34pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)
NWC/Revenue 0.02% (prev 0.40%; Δ -0.38pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)
CFO/TA 0.15 (>3.0%) and CFO 107.8m > Net Income 63.1m (YES >=105%, WARN >=100%)
Net Debt (187.6m) to EBITDA (115.9m) ratio: 1.62 <= 3.0 (WARN <= 3.5)
Current Ratio 1.00 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)
Outstanding Shares last Quarter (55.6m) change vs 12m ago 1.24% (target <= -2.0% for YES)
Gross Margin 49.65% (prev 46.46%; Δ 3.19pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)
Asset Turnover 111.9% (prev 100.1%; Δ 11.82pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)
Interest Coverage Ratio 10.78 (EBITDA TTM 115.9m / Interest Expense TTM 6.99m) >= 6 (WARN >= 3)

Altman Z'' 1.27

(A) 0.00 = (Total Current Assets 185.2m - Total Current Liabilities 185.0m) / Total Assets 740.8m
(B) 0.11 = Retained Earnings (Balance) 82.8m / Total Assets 740.8m
(C) 0.10 = EBIT TTM 75.3m / Avg Total Assets 723.4m
(D) 0.19 = Book Value of Equity 83.8m / Total Liabilities 434.0m
Total Rating: 1.27 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 79.77

1. Piotroski 7.50pt = 2.50
2. FCF Yield 5.44% = 2.72
3. FCF Margin 9.23% = 2.31
4. Debt/Equity 0.30 = 2.46
5. Debt/Ebitda 0.80 = 2.03
6. ROIC - WACC 5.11% = 6.39
7. RoE 22.12% = 1.84
8. Rev. Trend 90.65% = 4.53
9. Rev. CAGR 22.68% = 2.50
10. EPS Trend data missing
11. EPS CAGR 32.43% = 2.50

What is the price of UTI shares?

As of August 16, 2025, the stock is trading at USD 26.03 with a total of 1,387,280 shares traded.
Over the past week, the price has changed by -3.09%, over one month by -18.48%, over three months by -22.83% and over the past year by +49.77%.

Is Universal Technical a good stock to buy?

Partly, yes. Based on ValueRay´s Fundamental Analyses, Universal Technical (NYSE:UTI) is currently (August 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 79.77 and therefor a somewhat positive outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of UTI is around 27.24 USD . This means that UTI is currently overvalued and has a potential downside of 4.65%.

Is UTI a buy, sell or hold?

Universal Technical has received a consensus analysts rating of 4.83. Therefore, it is recommended to buy UTI.
  • Strong Buy: 5
  • Buy: 1
  • Hold: 0
  • Sell: 0
  • Strong Sell: 0

What are the forecasts/targets for the UTI price?

Issuer Target Up/Down from current
Wallstreet Target Price 37.6 44.4%
Analysts Target Price 37.3 43.4%
ValueRay Target Price 30.6 17.6%

Last update: 2025-08-13 02:51

UTI Fundamental Data Overview

Market Cap USD = 1.40b (1.40b USD * 1.0 USD.USD)
CCE Cash And Equivalents = 120.6m USD (Cash And Short Term Investments, last quarter)
P/E Trailing = 22.2069
P/E Forward = 25.3165
P/S = 1.7318
P/B = 4.7649
P/EG = 1.6893
Beta = 1.585
Revenue TTM = 809.5m USD
EBIT TTM = 75.3m USD
EBITDA TTM = 115.9m USD
Long Term Debt = 70.9m USD (from longTermDebt, last quarter)
Short Term Debt = 21.6m USD (from shortTermDebt, last quarter)
Debt = 92.5m USD (Calculated: Short Term 21.6m + Long Term 70.9m)
Net Debt = 187.6m USD (from netDebt column, last quarter)
Enterprise Value = 1.37b USD (1.40b + Debt 92.5m - CCE 120.6m)
Interest Coverage Ratio = 10.78 (Ebit TTM 75.3m / Interest Expense TTM 6.99m)
FCF Yield = 5.44% (FCF TTM 74.7m / Enterprise Value 1.37b)
FCF Margin = 9.23% (FCF TTM 74.7m / Revenue TTM 809.5m)
Net Margin = 7.79% (Net Income TTM 63.1m / Revenue TTM 809.5m)
Gross Margin = 49.65% ((Revenue TTM 809.5m - Cost of Revenue TTM 407.6m) / Revenue TTM)
Tobins Q-Ratio = 16.40 (Enterprise Value 1.37b / Book Value Of Equity 83.8m)
Interest Expense / Debt = 1.51% (Interest Expense 1.39m / Debt 92.5m)
Taxrate = 25.30% (from yearly Income Tax Expense: 14.2m / 56.2m)
NOPAT = 56.3m (EBIT 75.3m * (1 - 25.30%))
Current Ratio = 1.00 (Total Current Assets 185.2m / Total Current Liabilities 185.0m)
Debt / Equity = 0.30 (Debt 92.5m / last Quarter total Stockholder Equity 306.8m)
Debt / EBITDA = 0.80 (Net Debt 187.6m / EBITDA 115.9m)
Debt / FCF = 1.24 (Debt 92.5m / FCF TTM 74.7m)
Total Stockholder Equity = 285.2m (last 4 quarters mean)
RoA = 8.52% (Net Income 63.1m, Total Assets 740.8m )
RoE = 22.12% (Net Income TTM 63.1m / Total Stockholder Equity 285.2m)
RoCE = 21.15% (Ebit 75.3m / (Equity 285.2m + L.T.Debt 70.9m))
RoIC = 14.48% (NOPAT 56.3m / Invested Capital 388.7m)
WACC = 9.37% (E(1.40b)/V(1.49b) * Re(9.91%)) + (D(92.5m)/V(1.49b) * Rd(1.51%) * (1-Tc(0.25)))
Shares Correlation 5-Years: 100.0 | Cagr: 10.63%
Discount Rate = 9.91% (= CAPM, Blume Beta Adj.)
[DCF Debug] Terminal Value 60.74% ; FCFE base≈63.9m ; Y1≈39.3m ; Y5≈15.7m
Fair Price DCF = 4.42 (DCF Value 240.7m / Shares Outstanding 54.4m; 5y FCF grow -44.57% → 3.0% )
Revenue Correlation: 90.65 | Revenue CAGR: 22.68%
Revenue Growth Correlation: -75.43%
EPS Correlation: N/A | EPS CAGR: 32.43%
EPS Growth Correlation: -4.33%

Additional Sources for UTI Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle